Get to Know Dr. Evan Osmundson
Dr. Evan Osmundson is part of the radiation oncology team at Vanderbilt-Ingram that uses state-of-the-art technology to fight cancer through a multidisciplinary approach to treatment.
Techniques include intensity modulated radiotherapy, stereotactic radiosurgery, brachytherapy and intraoperative radiation therapy, all with continuous review of patient treatment outcomes.
He works closely with pathologists, thoracic surgeons and medical oncologists, making sure patients receive the best possible care through a multimodal approach that is prioritized at Vanderbilt-Ingram.
“It’s very, very important, and essential, particularly in radiation oncology, where we rely heavily on imaging for our treatment planning,” Osmundson said. “It [a multidisciplinary approach] is absolutely essential in providing the best, individualized care.”
Involved in Collaborative Research
Osmundson is part of a lung cancer tumor board that meets weekly with the different specialists to devise the most effective strategy to treating individual patients.
He is also part of a radiation research team that has collaborated with renowned faculty from around the world in making advances to the field.
His research projects include genomic stress response and cell cycle control, among other topics.
Recent clinical research has involved the patterns of rare malignancies such as mesothelioma, Tumor Treating Fields and novel PET biomarkers.
Osmundson was the lead author in one study of stereotactic body radiation therapy and predictors of toxicity to the hepatobiliary tract. He co-authored another study involving the same radiation therapy and central liver toxicity.
Proud to be at Vanderbilt
Osmundson earned his medical degree from the University of Illinois, where he also received a Ph.D.
He received his Bachelor of Science degree from California State Polytechnic University.
In addition to treating mesothelioma, Osmundson’s specialties include liver and lung cancers. He also treats patients with head and neck cancers, along with upper-airway, oral, nasal and lip malignancies.
As a Designated Comprehensive Cancer Center by the National Cancer Institute, Vanderbilt-Ingram is among the leaders in innovation, treatment and research, attracting patients from across the state and beyond.
“At Vanderbilt, we have a large catchment area,” he said. “There are a lot of patients who come to Vanderbilt looking for that second opinion, or whose provider felt the case was complex enough to warrant our multidisciplinary expertise.”
Thank you for your feedback. Would you like to speak with a Patient Advocate?